Hmdb loader
Record Information
Version5.0
StatusPredicted
Creation Date2021-09-17 04:51:30 UTC
Update Date2022-11-30 20:07:55 UTC
HMDB IDHMDB0292108
Secondary Accession NumbersNone
Metabolite Identification
Common NameCDP-DG(PGF1alpha/20:3(8Z,11Z,14Z))
DescriptionCDP-DG(PGF1alpha/20:3(8Z,11Z,14Z)) is an oxidized CDP-diacylglycerol (CDP-DG). Oxidized CDP-diacylglycerols are glycerophospholipids in which a cytidine diphosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized CDP-diacylglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396 ). As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. CDP-DG(PGF1alpha/20:3(8Z,11Z,14Z)), in particular, consists of one chain of one Prostaglandin F1alpha at the C-1 position and one chain of 8Z,11Z,14Z-eicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized CDP-DGs can be synthesized via three different routes. In one route, the oxidized CDP-DG is synthetized de novo following the same mechanisms as for CDP-DGs but incorporating oxidized acyl chains (PMID: 33329396 ). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396 ). The third pathway results from the oxidation of the acyl chain while still attached to the CDP-DG backbone, mainly through the action of LOX (PMID: 33329396 ).
Structure
Thumb
Synonyms
ValueSource
(1R,9R,19S,20S,22R,23S,24S,25S,27R)-4,6,20,22,24,25-Hexahydroxy-27-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)-23-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4,6-diphosphabicyclo[17.6.2]heptacosan-9-yl (8Z,11Z,14Z)-icosa-8,11,14-trienoic acidGenerator
Chemical FormulaC52H87N3O18P2
Average Molecular Weight1104.219
Monoisotopic Molecular Weight1103.545986969
IUPAC Name(1R,9R,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4lambda5,6lambda5-diphosphabicyclo[17.6.2]heptacosan-9-yl (8Z,11Z,14Z)-icosa-8,11,14-trienoate
Traditional Name(1R,9R,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4lambda5,6lambda5-diphosphabicyclo[17.6.2]heptacosan-9-yl (8Z,11Z,14Z)-icosa-8,11,14-trienoate
CAS Registry NumberNot Available
SMILES
CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(=O)O[C@@H]1COC(=O)CCCCCC[C@H]2[C@@H](O)C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC1)O[C@H]2N1C=CC(N)=NC1=O
InChI Identifier
InChI=1S/C52H87N3O18P2/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26-30-48(60)71-40-36-68-47(59)29-25-22-21-24-28-42-44(58)35-43(57)41(32-31-39(56)27-23-6-4-2)49(61)50(62)45(38-70-75(66,67)73-74(64,65)69-37-40)72-51(42)55-34-33-46(53)54-52(55)63/h9-10,12-13,15-16,31-34,39-45,49-51,56-58,61-62H,3-8,11,14,17-30,35-38H2,1-2H3,(H,64,65)(H,66,67)(H2,53,54,63)/b10-9-,13-12-,16-15-,32-31+/t39-,40+,41-,42-,43+,44-,45+,49-,50+,51+/m0/s1
InChI KeyBUJBHURWVXDFAY-NRDLADORSA-N
Chemical Taxonomy
ClassificationNot classified
Ontology
Physiological effectNot Available
DispositionNot Available
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.97ALOGPS
logP6.68ChemAxon
logS-4.4ALOGPS
pKa (Strongest Acidic)1.87ChemAxon
pKa (Strongest Basic)0.41ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count15ChemAxon
Hydrogen Donor Count8ChemAxon
Polar Surface Area323.96 ŲChemAxon
Rotatable Bond Count24ChemAxon
Refractivity284.14 m³·mol⁻¹ChemAxon
Polarizability116.96 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+318.44432859911
AllCCS[M+H-H2O]+319.01432859911
AllCCS[M+Na]+317.71632859911
AllCCS[M+NH4]+317.88432859911
AllCCS[M-H]-305.84432859911
AllCCS[M+Na-2H]-312.2232859911
AllCCS[M+HCOO]-319.1232859911
DeepCCS[M+H]+331.36530932474
DeepCCS[M-H]-329.71230932474
DeepCCS[M-2H]-363.74730932474
DeepCCS[M+Na]+337.52230932474

Predicted Kovats Retention Indices

Not Available
Spectra

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - CDP-DG(PGF1alpha/20:3(8Z,11Z,14Z)) 10V, Positive-QTOFsplash10-0gw0-6900000000-25ec24a350c6d05a8dee2021-10-21Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - CDP-DG(PGF1alpha/20:3(8Z,11Z,14Z)) 20V, Positive-QTOFsplash10-0673-9200000006-f7c923fb48cc2f0bd63b2021-10-21Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - CDP-DG(PGF1alpha/20:3(8Z,11Z,14Z)) 40V, Positive-QTOFsplash10-0g7j-7700000951-9e2241c6a8b14766e4752021-10-21Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - CDP-DG(PGF1alpha/20:3(8Z,11Z,14Z)) 10V, Negative-QTOFsplash10-0udi-1900000000-1ae956e7fa24706387232021-10-21Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - CDP-DG(PGF1alpha/20:3(8Z,11Z,14Z)) 20V, Negative-QTOFsplash10-0nna-5912000840-745c8465b1037575070c2021-10-21Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - CDP-DG(PGF1alpha/20:3(8Z,11Z,14Z)) 40V, Negative-QTOFsplash10-01ot-3300000900-944dfd5983d83fcf299f2021-10-21Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Hajeyah AA, Griffiths WJ, Wang Y, Finch AJ, O'Donnell VB: The Biosynthesis of Enzymatically Oxidized Lipids. Front Endocrinol (Lausanne). 2020 Nov 19;11:591819. doi: 10.3389/fendo.2020.591819. eCollection 2020. [PubMed:33329396 ]